George Washington and Minnesota universities-founded cell therapy developer Catamaran has raised cash to move two assets toward the clinic.

GV is among the investors in the pharmaceutical manufacturing technology startup, which recently secured $750m in series B funding.

Cathay Innovation led the Recruit-backed business documentation services provider's latest round, bringing its overall funding to about $75m.

The Comcast and Anthem-backed telemedicine app developer closed its second round of the year, at a reported $700m valuation.

Emissions measurement provider Aclima has raised cash in a round that included Splunk, RBVC and Microsoft Climate Innovation Fund.

Returning investor ClalTech helped take the transcription and remote education tool developer's total funding to $125m.

Tencent, Square and Telecom Italia unit TIM Ventures co-led an $80.6m round for the mobile payment platform developer alongside a $29.6m secondary investment.

Strategic partner PPD returned for a round that helped the clinical trial software provider take its total funding past the $130m mark.

Pharmaron Investments, Amgen Ventures and MRL Ventures Fund helped the bone marrow cancer drug developer double its total funding to about $160m.

The Naspers and Benasse-backed online skills platform developer hiked its valuation to $3.25bn and its total funding to more than $280m.